These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2355241)

  • 1. Cause of death among patients with Parkinson's disease: a rare mortality due to cerebral haemorrhage.
    Iwasaki S; Narabayashi Y; Hamaguchi K; Iwasaki A; Takakusagi M
    J Neurol; 1990 Apr; 237(2):77-9. PubMed ID: 2355241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of stroke in Parkinson's disease: a postmortem study.
    Mastaglia FL; Johnsen RD; Kakulas BA
    Mov Disord; 2002 Jul; 17(4):772-4. PubMed ID: 12210874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential inquiry.
    Ben-Shlomo Y; Churchyard A; Head J; Hurwitz B; Overstall P; Ockelford J; Lees AJ
    BMJ; 1998 Apr; 316(7139):1191-6. PubMed ID: 9583926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local cerebral blood flow and its response to intravenous levodopa in progressive supranuclear palsy. Comparison with Parkinson's disease.
    Kobari M; Fukuuchi Y; Shinohara T; Nogawa S; Takahashi K
    Arch Neurol; 1992 Jul; 49(7):725-30. PubMed ID: 1497499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hospital Mortality in Parkinson's Disease: Retrospective Analysis in a Portuguese Tertiary Centre].
    Martins J; Rua A; Vila Chã N
    Acta Med Port; 2016 May; 29(5):315-8. PubMed ID: 27649015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypotensive effect of long-term levodopa in patients with Parkinson's disease.
    Iwasaki S; Hamaguchi K; Iwasaki A; Takakusagi M; Narabayashi Y
    Eur Neurol; 1990; 30(4):194-9. PubMed ID: 2209672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levodopa improves spatial contrast sensitivity in Parkinson's disease.
    Hutton JT; Morris JL; Elias JW
    Arch Neurol; 1993 Jul; 50(7):721-4. PubMed ID: 8323475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of levodopa on word intelligibility in Parkinson's disease.
    De Letter M; Santens P; Van Borsel J
    J Commun Disord; 2005; 38(3):187-96. PubMed ID: 15748723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudden death in Parkinson's disease: a retrospective autopsy study.
    Matsumoto H; Sengoku R; Saito Y; Kakuta Y; Murayama S; Imafuku I
    J Neurol Sci; 2014 Aug; 343(1-2):149-52. PubMed ID: 24928079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom.
    Lees AJ
    BMJ; 1995 Dec; 311(7020):1602-7. PubMed ID: 8555803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher mortality due to intracerebral hemorrhage in dialysis patients: a comparison with the general population in Japan.
    Wakasugi M; Matsuo K; Kazama JJ; Narita I
    Ther Apher Dial; 2015 Feb; 19(1):45-9. PubMed ID: 25196294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of levodopa and viscosity on the velocity and accuracy of visually guided tracking in Parkinson's disease.
    Johnson MT; Kipnis AN; Coltz JD; Gupta A; Silverstein P; Zwiebel F; Ebner TJ
    Brain; 1996 Jun; 119 ( Pt 3)():801-13. PubMed ID: 8673492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective cohort study of perceived noise exposure at work and cerebrovascular diseases among male workers in Japan.
    Fujino Y; Iso H; Tamakoshi A;
    J Occup Health; 2007 Sep; 49(5):382-8. PubMed ID: 17951970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of levodopa on pulmonary function in Parkinson's disease: a systematic review and meta-analysis.
    Monteiro L; Souza-Machado A; Valderramas S; Melo A
    Clin Ther; 2012 May; 34(5):1049-55. PubMed ID: 22465616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonergic mechanisms in levodopa-induced "on-off" and sleep disorders in Parkinson's disease.
    Sandyk R
    Int J Neurosci; 1988 Dec; 43(3-4):207-13. PubMed ID: 3243678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of Parkinson's disease in Japan. Tottori University Parkinson's Disease Epidemiology (TUPDE) Study Group.
    Nakashima K; Maeda M; Tabata M; Adachi Y; Kusumi M; Ohshiro H
    Eur Neurol; 1997; 38 Suppl 2():60-3. PubMed ID: 9387805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years.
    Hely MA; Morris JG; Traficante R; Reid WG; O'Sullivan DJ; Williamson PM
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):300-7. PubMed ID: 10449550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical course and cause of death in elderly patients with idiopathic Parkinson's disease.
    Wang X; You G; Chen H; Cai X
    Chin Med J (Engl); 2002 Sep; 115(9):1409-11. PubMed ID: 12411124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of levodopa therapy in patients with Parkinson's disease: statistical evidence for reduced tolerance to levodopa in the elderly.
    Grad B; Wener J; Rosenberg G; Wener SW
    J Am Geriatr Soc; 1974 Nov; 22(11):489-94. PubMed ID: 4418704
    [No Abstract]   [Full Text] [Related]  

  • 20. Levodopa-induced local cerebral blood flow changes in Parkinson's disease and related disorders.
    Kobari M; Fukuuchi Y; Shinohara T; Obara K; Nogawa S
    J Neurol Sci; 1995 Feb; 128(2):212-8. PubMed ID: 7738597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.